GlassScriptPhysician profile
Aaron L Cernero
NPI 1194767350
$5,652.25
in general payments reported to CMS, 2019-2025
29 companies · $300 in 2025
The $300 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,308 · 2020: $374 · 2021: $250 · 2022: $172 · 2023: $736 · 2024: $513 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,302 · Long Term Medical Supply Or Device Loan: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,302.18 |
| Long Term Medical Supply Or Device Loan | $246.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,825.74 | 2019-2023 | Da Vinci Surgical System |
| Integra Lifesciences Corporation | $302.45 | 2024 | Acell, Integra, Primatrix |
| Baxter Healthcare | $199.01 | 2022-2025 | Tisseel |
| Conmed Corporation | $185.23 | 2021 | |
| Ethicon US, LLC | $160.79 | 2019-2025 | Echelon Flex, Proximate, Echelon; Endopath |
| Endo Pharmaceuticals INC. | $141.59 | 2019-2022 | |
| Davol INC. | $121.22 | 2019-2023 | Arista Ah Flexitip |
| Tela Bio, INC. | $93.80 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Currax Pharmaceuticals LLC | $71.08 | 2020-2023 | Contrave |
| Medtronic, INC. | $54.43 | 2023-2024 | Signia, Progrip |
| Cumberland Pharmaceuticals, INC. | $48.38 | 2024 | Caldolor |
| Biotissue Holdings INC. | $46.59 | 2023 | |
| Acell, INC. | $40.12 | 2019 | |
| Allergan, INC. | $39.81 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $35.53 | 2025 | Exparel |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $33.25 | 2019-2020 | |
| Innovation Technologies INC | $31.17 | 2023 | Irrisept |
| Echosens North America, INC. | $22.92 | 2024 | Fibroscan |
| Smith+Nephew, INC. | $22.14 | 2025 | Pico 14 |
| Solventum Corporation | $21.94 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Novo Nordisk INC | $21.36 | 2025 | Wegovy |
| Shire North American Group INC | $20.38 | 2019 | |
| Teleflex LLC | $18.19 | 2020 | |
| Lilly USA, LLC | $18.12 | 2024 | Zepbound |
| Rhythm Pharmaceuticals, INC. | $17.77 | 2024 | Imcivree |
| Reprise Biomedical, INC. | $17.52 | 2023 | Miroflex, Miro3d Fibers, Miro3d |
| Mimedx Group, INC. | $15.86 | 2025 | |
| Levita Magnetics International Corp. | $14.90 | 2024 | Toothed Grasper, Magnetic Surgical System |
| Covidien LP | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Cernero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.